Latest Revenue Growth News

Apiam Animal Health reported modest revenue growth but a sharp net profit decline in FY25, launching a Strategic Reset program under new leadership. The company also received a $0.88 per share acquisition proposal from Adamantem Capital Management.

Sigma Healthcare reports a robust FY25 performance post-merger with Chemist Warehouse Group, delivering strong revenue growth and upgraded synergy targets. The company signals continued expansion and efficiency gains heading into FY26.

Clever Culture Systems has validated and launched an AI-driven analysis module for smaller contact plates, significantly expanding its pharmaceutical market reach and recurring revenue potential.

EDU Holdings Limited has reported a remarkable half-year performance for 2025, with revenue more than doubling and profitability surging, prompting the company to declare its first-ever interim dividend.

Atturra Limited reported a robust 24% increase in revenue and underlying EBITDA for FY25, driven by six strategic acquisitions and expanded government contracts. Despite a slight dip in net profit, the company is poised for further growth with a 10% share buyback and a strong focus on AI and enterprise solutions.

SiteMinder Limited reported robust FY25 results with a 27.2% constant currency organic ARR increase and a return to positive underlying EBITDA, driven by its innovative Smart Platform and expanding global footprint.

SiteMinder Limited reported a strong FY25 with accelerated recurring revenue growth and, for the first time, positive underlying EBITDA and free cash flow, driven by its Smart Platform initiatives. The company sets ambitious guidance for FY26, aiming to scale its innovative hotel distribution and revenue management products globally.

SiteMinder Limited reported a 17.7% revenue increase to $224.3 million in FY2025, alongside a reduced net loss and positive underlying EBITDA, driven by its innovative Smart Platform strategy and expanding customer base.

ParagonCare Limited reported a solid FY25 with $3.6 billion in revenue and $95.2 million underlying EBITDA, marking progress in its integration and growth strategy across Asia Pacific. The company is poised for further profitability improvements and expansion in FY26.

Paragon Care Limited reported solid FY25 results with revenue climbing to $3.61 billion and underlying EBITDA rising 3%, driven by successful integration and expansion into new healthcare segments.

Paragon Care Limited reported a robust 22% increase in revenue to $3.61 billion for FY25, driven by organic growth and key acquisitions including CH2 Holdings and Oborne Health Supplies. The company also refinanced its debt facilities and expanded into the dental market post-year-end.

MyEco Group Ltd reported an 8.6% revenue increase to $15.7 million in FY25, driven by strong growth in its MyEco® branded products and improved margins. The company cut its net loss by nearly half, supported by operational restructuring and expanding market presence.